Cargando…

PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis

Clear cell renal cell carcinoma (ccRCC) is one of the most lethal urological malignancies with high tumor heterogeneity, and reliable biomarkers are still needed for its diagnosis and prognosis. WEE family kinases function as key regulators of the G2/M transition, have essential roles in maintaining...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Juan, Hua, Xiaoliang, Chen, Heying, Qiu, Xiangmin, Xiao, Haibing, Ge, Shengdong, Liang, Chaozhao, Zhou, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751600/ https://www.ncbi.nlm.nih.gov/pubmed/34959223 http://dx.doi.org/10.18632/aging.203759

Ejemplares similares

A costimulatory molecule-related signature in regard to evaluation of prognosis and immune features for clear cell renal cell carcinoma
por: Hua, Xiaoliang, et al.
Publicado: (2021)

Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Chen, Peng, et al.
Publicado: (2020)

Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Hua, Xiaoliang, et al.
Publicado: (2020)

Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Tang, Yuting, et al.
Publicado: (2022)

PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis Resistance
por: Zhang, Qi-Yong, et al.
Publicado: (2020)

Effects of RNA Binding Proteins on the Prognosis and Malignant Progression in Prostate Cancer
por: Hua, Xiaoliang, et al.
Publicado: (2020)

Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
por: Ge, Shengdong, et al.
Publicado: (2021)

The DNA damage repair-related gene PKMYT1 is a potential biomarker in various malignancies
por: Shao, Changjian, et al.
Publicado: (2021)

TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma
por: Yan, Youji, et al.
Publicado: (2019)

PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma
por: Long, Huan-ping, et al.
Publicado: (2020)

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition
por: Gallo, David, et al.
Publicado: (2022)

ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma
por: Qiu, Xiangmin, et al.
Publicado: (2020)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

PKMYT1 regulates the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma cells by targeting CCNA2
por: Cai, Ye, et al.
Publicado: (2022)

Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
por: Schmidt, Matthias, et al.
Publicado: (2017)

Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma
por: Chao, Xiaoyu, et al.
Publicado: (2021)

Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients
por: Tao, Junyue, et al.
Publicado: (2022)

Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
por: D'Aniello, Carmine, et al.
Publicado: (2019)

Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis
por: Chang, Peng, et al.
Publicado: (2018)

Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
por: Wang, Hongzhi, et al.
Publicado: (2021)

Systematic expression analysis of WEE family kinases reveals the importance of PKMYT1 in breast carcinogenesis
por: Liu, Yu, et al.
Publicado: (2019)

The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma
por: Zhou, Yongying, et al.
Publicado: (2021)

Long Noncoding RNA HOTTIP Serves as an Independent Predictive Biomarker for the Prognosis of Patients with Clear Cell Renal Cell Carcinoma
por: Liu, Zhanxin, et al.
Publicado: (2020)

c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1
por: Luo, Peng, et al.
Publicado: (2022)

VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma
por: Ha, Mihyang, et al.
Publicado: (2019)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
por: Chen, Jiasheng, et al.
Publicado: (2022)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022)

Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification
por: Hu, Yiyang, et al.
Publicado: (2022)

Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis
por: Chen, Liang, et al.
Publicado: (2018)

ASNS can predict the poor prognosis of clear cell renal cell carcinoma
por: Gan, Xinqiang, et al.
Publicado: (2022)

Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma
por: Zhong, Tingting, et al.
Publicado: (2022)

Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
por: Zhang, Ning, et al.
Publicado: (2020)

Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
por: Su, Yang, et al.
Publicado: (2021)

OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
por: Wei, Shuzhang, et al.
Publicado: (2023)

A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma
por: Meng, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bstgvia8m356pg8b4dja271bln